Today is June 27, 2024.
All times in Eastern Daylight Time.
-
KalVista Pharmaceuticals Presents Data on Persisting Unmet Needs in Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that it presented real-world data from US patient surveys that assessed the ex... more »
-
Ault Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to Stockholders
LAS VEGAS--(BUSINESS WIRE)--Ault Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to Stockholders more »
-
Edwards Lifesciences to Sell Critical Care to BD
IRVINE, CA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company)... more »
-
Jack in the Box Announces Continued Florida Expansion with New Franchise Commitments
SAN DIEGO, Calif.--(BUSINESS WIRE)--Jack in the Box Inc. (NASDAQ: JACK), a leading national quick-service restaurant company, today announced significant progress in its Florida expansion plans wit... more »
-
Gartner Announces Gartner Marketing Symposium/Xpo in Denver
STAMFORD, Conn.--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT): What: Gartner Marketing Symposium/Xpo When: June 3-5, 2024 Where: Denver, CO Members of the media can register for the conference by cont... more »
-
Genesis Energy, L.P. to Participate in Investor Conferences
HOUSTON--(BUSINESS WIRE)--Genesis Energy, L.P. (NYSE: GEL) announced today that it will host investor meetings at the following conferences: 2024 RBC Capital Markets Global Energy, Power & Infr... more »
-
ezCater Names Kaushik Subramanian as Chief Revenue Officer
BOSTON--(BUSINESS WIRE)--ezCater, the leading food for work technology company in the US, today announced it has named Kaushik Subramanian as Chief Revenue Officer, effective June 3, 2024. Subraman... more »
-
Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases... more »
-
Walker & Dunlop Lists Milhaus’ Artistry, Indianapolis’ Iconic Mixed Use Apartment Complex
BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop, Inc.'s Midwest Investment Sales team announces its role as the exclusive advisor for Artistry, an iconic mixed use apartment complex in the corn... more »
-
Xylem Scales Sustainability Impacts with New Water Stewardship Commitments
WASHINGTON--(BUSINESS WIRE)--Global water technology leader Xylem (NYSE: XYL) is expanding its sustainability commitments with new 2030 water stewardship goals, following the company’s combination ... more »
-
Summit Raises $200 Million; Also Expands License Territories for Ivonescimab
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that the Company received and accepted an unsolicited offer from an institutional ... more »
-
Eutelsat Group Achieves Platinum Score in Space Sustainability Rating
PARIS--(BUSINESS WIRE)--Eutelsat Group achieves Platinum Score in Space Sustainability Rating more »
-
Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors
BARCELONA, Spain--(BUSINESS WIRE)--Germans Trias i Pujol Hospital in Spain is launching a breakthrough telehealth program using Masimo wearable technology and Hospital Automation™. more »
-
Ferguson Files Form 8-K
WOKINGHAM, England--(BUSINESS WIRE)--On May 31, 2024, Ferguson plc (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"). It is available on the SEC's website at... more »
-
Discover® Global Network Study Shows 85% of Consumers are Less Likely to Interact with a Business Due to a Poor Payment Experience
RIVERWOODS, Ill.--(BUSINESS WIRE)--Discover Global Network®, a leading global payment network, released the first portion of the 2024 Payment State of the Union (PSOU), one of the most comprehensiv... more »
-
WEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
LOS ANGELES--(BUSINESS WIRE)--WEBTOON Entertainment Inc. (“WEBTOON” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytelling platforms, today a... more »
-
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bis... more »
-
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
PHILADELPHIA--(BUSINESS WIRE)--Belantamab Mafodotin combo reduced the risk of disease progression or death by nearly 50% versus SOC combo in relapsed/refractory multiple myeloma more »
-
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that findings from the Phase II trial of its drug alisertib (TBCRC 041) were presented at the ASCO 2024 Annual Meeting. more »
-
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced new data from Cohort B of ARC-9, a Phase 1b/2 s... more »
-
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
FOSTER CITY, Calif. & HAYWARD, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced new data from Cohort B of ARC-9, a Phase 1b/2 s... more »
-
ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--ENHERTU Demonstrated a Median PFS of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow mBC Following One or More Lines of Endocrine Therapy more »
-
New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of seven ... more »
-
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new patient- and physician... more »
-
ADSK Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Autodesk, Inc. - Contact Kessler Topaz Meltzer & Check, LLP
RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States Dist... more »
|
|